Related Experiment Videos
Clinical aspects of hypoxic pulmonary vasoconstriction
1Department of Intensive Care Medicine, Guy's and St Thomas' Hospital Trust, London, UK.
Experimental Physiology
|September 1, 1995
Summary
Hypoxic pulmonary vascular disease contributes to illness and death. New therapies target its mechanisms, offering hope beyond current treatments like oxygen and vasodilators.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Research
- Hypoxia Studies
Background:
- Hypoxic pulmonary vascular disease is often overlooked but significantly impacts patient outcomes.
- The body's response to hypoxia involves acute vasoconstriction and long-term vascular remodeling.
- Current treatments for hypoxic pulmonary vascular disease are limited.
Purpose of the Study:
- To review the mechanisms of hypoxic pulmonary vascular disease.
- To discuss current and emerging therapeutic strategies.
- To highlight advances in managing acute hypoxic pulmonary vasoconstriction.
Main Methods:
- Review of existing literature on hypoxic pulmonary vascular disease.
- Analysis of physiological responses to hypoxia.
- Evaluation of current and novel treatment modalities.
Main Results:
- Understanding of hypoxic response mechanisms has advanced significantly.
- Inhaled nitric oxide (NO) therapy shows promise for acute hypoxic pulmonary vasoconstriction.
- Specific treatments targeting underlying abnormalities are anticipated.
Conclusions:
- Hypoxic pulmonary vascular disease requires greater recognition.
- Inhaled NO therapy is a breakthrough for acute hypoxic pulmonary vasoconstriction.
- Future treatments may offer targeted correction of physiological abnormalities.